The Immunosuppressive Drug Mizoribine Directly Prevents Podocyte Injury in Puromycin Aminonucleoside Nephrosis

Publisher： Karger

E-ISSN： 1660-2129|116|1|e3-e10

ISSN： 1660-2129

Source： Nephron Experimental Nephrology, Vol.116, Iss.1, 2010-05, pp. : e3-e10

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Increased Apoptosis in Acute Puromycin Aminonucleoside Nephrosis

By  

Nephron Experimental Nephrology, Vol. 9, Iss. 2, 2001-01 ,pp. : 99-108

Karger

Access to resources Recommend Favorite

Permeability, Ultrastructural Changes, and Distribution of Novel Proteins in the Glomerular Barrier in Early Puromycin Aminonucleoside Nephrosis

By  

Nephron Experimental Nephrology, Vol. 116, Iss. 2, 2010-06 ,pp. : e42-e52

Karger

Access to resources Recommend Favorite

Increased Expression of CD54, CD18, MHC Class II Molecules, and Proliferating Cell Nuclear Antigen in Acute Puromycin Aminonucleoside Nephrosis

By  

Nephron Experimental Nephrology, Vol. 94, Iss. 2, 2004-11 ,pp. : e55-e65

Karger

Access to resources Recommend Favorite

Renal Alpha-Actinin-4: Purification and Puromycin Aminonucleoside-Binding Property

By  

Nephron Experimental Nephrology, Vol. 93, Iss. 1, 2004-11 ,pp. : e27-e35

Karger

Access to resources Recommend Favorite

Transcriptome Analysis of the Response of Cultured Murine Podocytes to Puromycin Aminonucleoside

By  

Nephron Experimental Nephrology, Vol. 115, Iss. 1, 2010-02 ,pp. : e1-e8

Karger

Access to resources Recommend Favorite